Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Merck KGaA lands FDA nod for joint tumor drug it licensed from Abbisko

Merck KGaA said Tuesday that the drug it licensed from a China-based biotech has secured FDA approval for rare noncancerous tumors that impact the joints. The German conglomerate got the

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 11 November →